Russia strikes Darnytsia pharmaceutical plant in Kyiv
Photo: The Darnytsia Pharmaceutical plant in Kyiv has once again come under attack (RBC-Ukraine)
Russian forces struck the Darnitsa pharmaceutical plant in Kyiv. There were no fatalities among the plant's employees, according to Kateryna Zagoriy, a member of the Strategic Council of the Darnitsa pharmaceutical company and co-founder of the Zagoriy Foundation.
The company confirms that Russia struck the facility but has not yet disclosed information about the nature of the damage or the consequences of the attack.
"For security reasons and until the relevant authorities have completed their work, we are not commenting on the details regarding the nature of the damage or the consequences. At this time, we can confirm that there were no fatalities among the employees," Zagoriy says.
She also urges people not to post photos or videos from the scene.
Details regarding the consequences of the strike are expected once the relevant authorities have completed their work.
Background
Darnytsia is a Ukrainian pharmaceutical company headquartered in Kyiv. The company manufactures over 200 brands of medications.
The company's medications cover areas such as cardiology, neurology, and pain management. The drugs are available in various forms—pills, capsules, ampoules, drops, and more.
Among Darnytsia's well-known medications are: Tsytramon-Darnytsia, Paratsetamol-Darnytsia, Analhin-Darnytsia, Mefenaminka, Darfen Express, Kaptopres-Darnytsia, Spironolacton-Darnytsia, Septefryl-Darnytsia, Medykhronal-Darnytsia, Darsil, and Adrenalin-Darnytsia.
In June 2026, Russian forces had already struck the Darnytsia pharmaceutical plant in Kyiv.
Recently, the company assessed the risk of a drug shortage and commented on how drug prices might be affected amid the Russian attacks.
